Building Panosome’s culture, conversation by conversation
At Panosome, we believe that advancing transformation in the biotech industry relies not just on scientific innovations but also a strong organizational culture.
Read moreANTIBODY DEVELOPMENT
Targeting the untargetable
Panosome turns a parasite's survival mechanism into a powerful engine for antibody innovation. Through our proprietary VAST platform, we are pioneering the development of highly specific antibodies against traditionally inaccessible targets in oncology, inflammation, biodefense, and beyond.
OUR UNIQUE APPROACH
Trypanosome Intelligence: Inspired by nature. Engineered for impact.
Many disease-driving targets remain inaccessible to conventional antibody technologies, often failing to trigger a strong immune response. To address these challenging targets, Panosome engineered the VAST (VSG-Immunogen Array by Sortase Tagging) technology. Our platform transforms the naturally immunogenic surface of African trypanosomes into a dense antigen display, powering the generation of high-affinity antibodies and opening new opportunities for clinical impact.
WHY PANOSOME
Pioneering new possibilities in antibody discovery
Proprietary Platform
Our antibody discovery platform is protected by a growing intellectual property portfolio.
Challenging Targets
We can reach target classes that remain unaddressed by conventional antibody generation approaches.
Broad Applications
Our approach has the potential to make an impact in oncology, inflammatory diseases, biodefense, and more.
Scalable Innovation
One versatile platform can be tuned to generate multiple antibody assets with high throughput.
FAST FACTS ON VAST
Numbers that make a difference
0 million
VSG molecules cover a single trypanosome surface to create a naturally immunogenic surface
0×
Larger platform than conventional carrier molecules, enhancing antigen recognition
0-in-1
Thousands of target-specific antigens can be generated in one modular display platform
NEWS & UPDATES
Stay updated about Panosome’s latest milestones, partnerships, and events.
Panosome wins BioVaria Rising Startup Award 2026
Panosome GmBH is honored to have received the BioVaria Rising Startup Award this 2026.
Read moreCONTACT US
Let’s start a conversation
Whether you are interested in research collaborations, partnerships, or general inquiries, feel free to reach out to our team.